Phytochemicals as Chemopreventive Agents: Mechanisms and Clinical Insights

Carcinoma is a significant worldwide health concern, with its prevalence and mortality increasing substantially in countries with low or middle incomes.  Preventative methods that are reliable, inexpensive, and durable are thus essential.  Phytochemicals, or bioactive molecules produced from plants, are being investigated as prospective cancer-preventing medicines because of their capacity to influence several molecular processes associated with malignancy.  The current article focuses on the impact of significant plant chemical categories such as polyphenols as well as terpenoids, alkaloid substances, and organosulfur molecules in fighting cancer. Antioxidant protection, control of carcinogens breakdown, modification of cell signaling systems like NF-κB, PI3K/Akt, and Wnt/β-catenin, epigenetic modification, apoptotic stimulation, angiogenesis suppression, and immunological regulation are some of the means by which these substances work. The curative properties of important phytochemicals like curcumin, resveratrol, epigallocatechin gallate, sulforaphane, lycopene, and quercetin is supported by data from in vitro, in vivo, and preliminary clinical investigations. Yet, their translational effectiveness is limited by issues with poor distribution, uneven medical results, and unpredictable kinetics. Potential methods to improve the effectiveness of treatment are provided by recent advancements in nanotechnologies, lipid-based formulations, and tailored nutrition techniques. All things considered, phytonutrients are an essential component of dietary and cancer chemotherapy avoidance, and they have tremendous opportunity to be incorporated into next cancer treatment tactics.